Table III.

Association of pSTAT3 and SOCS3 expression with clinicopathological parameters of the HCC patients.

Parameter	No.	pSTAT3 expression, n (%)	P-value	SOCS3-positive expression, n (%)	P-value
Age (years)			0.133		0.967
≤55	86	51 (59.3)		40 (46.5)
>55	52	24 (46.2)		24 (46.2)
Gender			0.252		0.222
Male	115	60 (52.2)		56 (48.7)
Female	23	15 (65.2)		8 (34.8)
Cirrhosis			0.533		0.986
Yes	125	69 (55.2)		58 (46.4)
No	13	6 (46.2)		6 (46.2)
HBsAg			0.888		0.513
Yes	111	60 (54.1)		53 (47.7)
No	27	15 (55.6)		11 (40.7)
Tumor size (cm)			0.001		0.137
<5	41	13 (31.7)		23 (56.1)
≥5	97	62 (63.9)		41 (42.3)
Grade			0.417		0.299
I	5	4 (80.0)		4 (80.0)
II	128	69 (53.9)		58 (45.3)
III	5	2 (40.0)		2 (40.0)
Stage			0.002		0.251
I–II	106	50 (47.2)		52 (49.1)
III–IV	32	25 (78.1)		12 (37.5)
Ki67			0.000		0.034
<50%	60	22 (36.7)		34 (56.7)
≥50%	78	53 (67.9)		30 (38.5)
VEGF			0.001		0.001
Negative	53	12 (22.6)		37 (69.8)
Positive	85	63 (74.1)		27 (31.8)